WHO ICTRP trial
An open randomised study to assess the efficacy of gatifloxacin versus…
ISRCTN53258327 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting
Key facts
| Trial ID | ISRCTN53258327 |
|---|---|
| Public title | An open randomised study to assess the efficacy of gatifloxacin versus chloramphenicol for the treatment of uncomplicated typhoid fever in Kathmandu, Nepal |
| Primary sponsor | University of Oxford (UK) |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | Nepal |
| Conditions | Typhoid fever Infections and Infestations Typhoid fever |
| Interventions | Gatifloxacin versus Chloramphenicol. Added as of 20/09/2007: This trial was stopped temporarily in September 2006 at the request of the Nepal Health Research Council and Department of Drug Administration after the reports of dysglycaemia… |
| Registration date | Nov 4, 2006 |
| Target size | 320 |
| Secondary IDs | 061330; OXTREC 002-06 |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: